First CDK4/6 Inhibitor OK'd for Early, High-Risk Breast Cancer Abemaciclib approved with endocrine therapy for hormone receptor-positive/HER2-negative disease Oct 13, 2021
Almost Half of Breast Cancer Patients Use Cannabis, Survey Finds Common reasons for use include pain, anxiety, nausea, and insomnia Oct 12, 2021
Women With Very Dense Breasts Benefit From MRI Screening Dutch researchers recommend screening with MRI every 4 years Oct 01, 2021
Different Taxanes, Similar Outcomes in Advanced HER2-Positive Breast Cancer Results from docetaxel-based study appear applicable to paclitaxel, nab-paclitaxel Sep 29, 2021
What's Behind the Racial Differences in Women's Cancer Screening? Existing medical conditions and social factors are likely driving gaps, researchers found Sep 24, 2021
In RA, Little Risk for Recurrent Cancer With Biologic Treatment Results important because most trials excluded patients with previous cancer, researchers note Sep 23, 2021
Chemo Plus Keytruda Boosts Overall Survival in Advanced TNBC KEYNOTE-355 regimen offers "transformative treatment" in PD-L1-positive disease, expert says Sep 20, 2021
Combo Treatment Extends Survival in HR+HER2- Advanced Breast Cancer MONALEESA-2's "big message": 12.5-month boost in median OS with ribociclib-aromatase inhibitor Sep 19, 2021
Trastuzumab Deruxtecan: New Standard of Care in Pretreated, Advanced Breast Cancer? DESTINY-Breast03 turns in "absolutely startling" PFS in HER2-positive metastatic disease Sep 18, 2021
Extended Letrozole Reduced Recurrence Risk in Postmenopausal Breast Cancer 5 years of the aromatase inhibitor improved disease-free survival vs 2-3 years Sep 17, 2021
Improved Survival With Surgery in Metastatic Breast Cancer Significant benefits in ER+, PR+, HER2+ disease, neoadjuvant vs adjuvant chemotherapy Aug 31, 2021
Benefits of Adjuvant Radiation in DCIS Persist Out to 15 Years Risk of ipsilateral breast recurrence more than halved in women with good-risk lesions Aug 27, 2021
Dense Breasts Linked to Increased Risk of Invasive Cancer in Older Women Breast density, life expectancy could be factored into considerations for continued screening Aug 27, 2021
Genentech Pulls Atezolizumab's Breast Cancer Approval Lack of FDA support amid "changes in the treatment landscape" cited in decision Aug 27, 2021
Breast Cancer Control Similar With Intermittent, Continuous Endocrine Therapy Better quality of life with treatment break during extended adjuvant therapy Aug 11, 2021
A Patient Care App Diagnosed Me With Cancer No one should receive a serious diagnosis this way -- not even a doctor like myself Jul 16, 2021
Keytruda Before, After Surgery Improves Outcome in TNBC Results from KEYNOTE-522 show "practice-changing" impact on EFS Jul 15, 2021
Raise a Glass? Study Tallies Cancer Cases From Booze Heavy drinking habits accounted for about half of new alcohol-associated cases Jul 13, 2021
Start Thinking 'Cure'; One More Hug; Mortgages and Breast Cancer Survival News, features, and commentary about cancer-related issues Jun 16, 2021
COVID Vaccine Protection; 'Until You Die From the Cancer'; What's Palliative Care? News, features, and commentary about cancer-related issues Jun 10, 2021
Bispecific Antibody Active in NRG1-Positive Pancreatic Cancer Zenocutuzumab turns in promising results in early-phase trial involving multiple solid tumors Jun 10, 2021
More Support for Gene Assay to Guide Breast Cancer Treatment More nuanced data on treatment de-escalation, extended endocrine therapy Jun 09, 2021
Novel CDK 4/6 Inhibitor Proves Mettle in HR+/HER2- Advanced Breast Cancer Dalpiciclib may be a new treatment option; palbociclib and ribociclib continue to shine Jun 06, 2021
Olaparib Wins in Early BRCA-Mutant Breast Cancer First trial to show adjuvant PARP inhibitor benefit inBRCA mutation carriers Jun 03, 2021
Lymph Node Findings on PET: Cancer or COVID Vaccine? Post-jab radiotracer uptake "could prompt unnecessary biopsies and treatments" May 26, 2021
RET Fusion Inhibitor Active Beyond Lung, Thyroid Cancers Responses to selpercatinib in almost half of tumors outside approved indications May 21, 2021
Breast Cancer and MS: New Data Shed Light on Survival Study compares breast cancer patients with and without MS May 19, 2021
A Call for Nuance in Cardioprotection With Early Breast Cancer Therapy Longer-term PRADA trial results weigh in for low-risk group May 16, 2021
Impressive Disease Control in Metastatic Triple-Negative Breast Cancer ESMO Breast: Reassuring safety data for dual anti-HER2 therapy, antibody-drug conjugate May 14, 2021
Chemo-Free Regimen Shows Promise in High-Risk Early Breast Cancer PFS and other outcomes with letrozole-palbociclib almost identical to chemotherapy May 12, 2021
SBRT Safe for Cancer Patients With Multiple Metastases Late adverse events in phase I trial indicate need for extended follow-up May 03, 2021
New Clues to Sleep Problems, Solutions in Cancer Patients Studies in GI and breast cancers zero in on sleep disturbance during active treatment Apr 30, 2021
Healthy Lifestyle May Mitigate Heart Risks for Young Cancer Survivors Literature reviews find particularly persistent cardiovascular complications in these patients Apr 28, 2021
Chemotherapy Nausea Linked to Stress, Neuropsych Symptoms High frequency of CIN leads to stress and more severe neuropsychological symptoms Apr 23, 2021
Auricular Acupressure May Relieve Neuropathy in Breast Cancer First randomized trial of the noninvasive technique in such patients Apr 22, 2021
Are Post-Mastectomy Lymphedema Precautions Needed for All? Standard risk reduction efforts may not decrease incidence, researchers say Apr 21, 2021
Triple-Negative Breast Cancers Not All the Same Histology tied to treatment response, outcomes Apr 12, 2021
Safety Reassurance for Major Class of Diabetes Drugs Pooled trial data show no link to breast cancer Mar 24, 2021
Time to Revisit Distant Nodal Status in Breast Cancer Curability? Comparable survival for distant and regional nodal involvement, when treated similarly Mar 16, 2021
